Engineering Immunity: T cell-driven immunotherapy and the future of medicine

Add to your list(s) Download to your calendar using vCal

• Michael Harris
• Tuesday 13 June 2017, 19:00-20:00
• YHA, 97 Tenison Rd, Cambridge CB1 2DN.

If you have a question about this talk, please contact Vasee.

Michael Harris, PhD student at the Department of Medicine, will talk about his study on T cell activation. T cells are key effectors and regulators of the immune response to infections and cancer. Recent decades have seen our understanding of the molecular mechanisms of T cell activation advance significantly. This knowledge is being used to engineer patient-specific immunotherapies and circumvent cancer’s immune-evasions mechanisms.

This talk is part of the SciBar Cambridge series.

This talk is included in these lists:

• SciBar Cambridge
• YHA, 97 Tenison Rd, Cambridge CB1 2DN
• se393's list

Note that ex-directory lists are not shown.